Kliniska studier för Lupus i Alabama
5 studier för Lupus söker deltagare vid platser i Alabama.
Städer i Alabama
Officiell studietext (engelska)
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Pinnacle Research Group Llc, Anniston
RekryterarFas 3
Ålder 12 till 100 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06133972A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Birmingham
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07430306A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Pinnacle Research Group /ID# 278677, Anniston
RekryterarFas 1
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07607964A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Anniston
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 15 sep. 2026 · NCT06916806Lupus Landmark Study: A Prospective Registry and Biorepository
- University of Alabama at Birmingham, Birmingham
RekryterarObservationsstudie
Ålder 18 till 110 · Alla kön · Uppdaterad 15 apr. 2026 · NCT05934149Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.